You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

angiotensin receptor neprilysin inhibitor

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Aortic Valve Stenosis Trial in Seoul (Angiotensin Receptor-Neprilysin Inhibitor, antihypertensive drugs including RAS inhibitors

Not yet recruiting
  • Aortic Valve Stenosis
  • Angiotensin Receptor-Neprilysin Inhibitor
  • antihypertensive drugs including RAS inhibitors (ACE inhibitors or ARB)
  • Seoul, Korea, Republic of
    Asan Medical Center
Jan 4, 2023

Novel Antidiabetic Drug Combined With Angiotensin

Recruiting
  • Type 2 Diabetes
  • Antidiabetic Drugs
    • Beijing, Beijing, China
    • +1 more
    Jun 20, 2023

    Heart Failure With Reduced Ejection Fraction Trial in Porto (Sacubitril-valsartan, SGLT2 inhibitor)

    Recruiting
    • Heart Failure With Reduced Ejection Fraction
    • Porto, Portugal
    • +3 more
    Aug 9, 2023

    ARNI and ACE Inhibitor/ARB Medication in Patient With HFrEF

    Recruiting
    • Heart Failure
    • Mortality
    • Angiotensin receptor neprilysin inhibitor (ARNI)
    • Renin-Angiotensin System Inhibitor (RAS inhibitor)
    • Wonju, Gangwondo, Korea, Republic of
      Yonsei University Wonju College of Medicine
    Dec 20, 2022

    Systemic Right Ventricle, Heart Failure Trial in Montreal (Sacubitril / Valsartan Oral Tablet, Placebo)

    Active, not recruiting
    • Systemic Right Ventricle
    • Heart Failure
    • Sacubitril / Valsartan Oral Tablet
    • Placebo
    • Montreal, Quebec, Canada
      Montreal Heart Institute
    Dec 21, 2022

    Hypertension, Left Ventricular Hypertrophy Trial in Shanghai (sacubitril/valsartan, Amlodipine)

    Recruiting
    • Hypertension
    • Left Ventricular Hypertrophy
    • Shanghai, China
      Shanghai Institite of Hypertension, Ruijin Hospital, Shanghai Ji
    Dec 7, 2021

    Stage D Heart Failure Trial in Cleveland (Sacubitril-Valsartan, Usual care (standard-of-care) arm)

    Recruiting
    • Stage D Heart Failure
    • Cleveland, Ohio
      Cleveland Clinic
    Jun 4, 2021

    Pulmonary Hypertension Trial in Badalona (Sacubitril / Valsartan Oral Tablet [Entresto])

    Completed
    • Pulmonary Hypertension
    • Sacubitril / Valsartan Oral Tablet [Entresto]
    • Badalona, Barcelona, Spain
      Germans Trias i Pujol University Hospital
    Sep 23, 2021

    Heart Failure, Systolic Trial in Karachi (Sacubitril/valsartan)

    Completed
    • Heart Failure, Systolic
    • Karachi, Sindh, Pakistan
      National Institute of Cardiovascular Diseases
    May 20, 2022

    Heart Failure Trial in Saga (Sacubitril Valsartan Sodium Hydrate, Standard treatment)

    Recruiting
    • Heart Failure
    • Sacubitril Valsartan Sodium Hydrate
    • Standard treatment
    • Saga, Japan
      Saga University Hospital
    Dec 27, 2021

    Chagas Cardiomyopathy Trial in São Paulo (Sacubitril / Valsartan Oral Tablet [Entresto], Enalapril)

    Recruiting
    • Chagas Cardiomyopathy
    • Sacubitril / Valsartan Oral Tablet [Entresto]
    • Enalapril
    • São Paulo, Brazil
      Heart Institute (Incor) University of Sao Paulo
    May 6, 2021

    Immune Checkpoint Inhibitor in NSCLC Patients

    Not yet recruiting
    • Adverse Reactions
    • +3 more
    • renin-angiotensin system inhibitors or angiotensin-receptor-neprilysin inhibitor
    • (no location specified)
    Jul 15, 2020

    Heart Failure With Preserved Ejection Fraction Trial in Chongqing (Angiotensin Receptor-Neprilysin Inhibition, Placebo)

    Not yet recruiting
    • Heart Failure With Preserved Ejection Fraction
    • Angiotensin Receptor-Neprilysin Inhibition
    • Placebo
    • Chongqing, China
      The first affiliated Hospital of Chongqing Medical University
    Oct 21, 2021

    Hypertrophic Cardiomyopathy Trial in Worldwide (Lifestyle, Sacubitril/Valsartan)

    Completed
    • Hypertrophic Cardiomyopathy
    • Regensburg, Germany
    • +4 more
    Nov 23, 2022

    Six Months Clinical and Echocardiographic Outcome of ARNI LCZ696

    Completed
    • Heart Failure With Reduced Ejection Fraction
    • LCZ 696
    • Cairo, Egypt
      Cairo University
    Jan 14, 2020

    Hypertrophic Cardiomyopathy Trial in Newcastle (Sacubitril/Valsartan, Lifestyle)

    Completed
    • Hypertrophic Cardiomyopathy
    • Newcastle, United Kingdom
      Newcastle NHS
    May 4, 2022

    The Effect of RAAS Blockers on ACE2 Levels

    Completed
    • Renin-Angiotensin System
    • ACE inhibitor ,angiotensin receptor blockers
    • Cairo, Select A State Or Province, Egypt
      Ainshams University
    Jun 10, 2022

    Heart Failure Trial in Gallup (EHR-based GDMT Optimization)

    Not yet recruiting
    • Heart Failure
    • EHR-based GDMT Optimization
    • Gallup, New Mexico
      Gallup Indian Medical Center
    Mar 17, 2023

    Heart Failure With Reduced Ejection Fraction Trial in Los Angeles (Email Nudge)

    Not yet recruiting
    • Heart Failure With Reduced Ejection Fraction
    • Email Nudge
    • Los Angeles, California
      University of California, Los Angeles
    Apr 7, 2023

    Cardiovascular Diseases, Diabetes, Type 2, Coronary Disease Trial in China (phone calls and encouraging patients' lifestyle

    Recruiting
    • Cardiovascular Diseases
    • +2 more
    • phone calls and encouraging patients' lifestyle change and medication adherence
    • Statin
    • Enshi, Hubei, China
    • +106 more
    Mar 12, 2023

    Acute Heart Failure Trial

    Not yet recruiting
    • Acute Heart Failure
      • (no location specified)
      May 9, 2023

      Hypertension Trial in London (Preoperative ACEi/ARB management)

      Completed
      • Hypertension
      • Preoperative ACEi/ARB management
      • London, Ontario, Canada
        London Health Sciences Centre
      Oct 21, 2021

      Diabetic Kidney Disease Trial in Australia (SER150, Placebo)

      Recruiting
      • Diabetic Kidney Disease
      • Liverpool, New South Wales, Australia
      • +6 more
      May 17, 2022

      Chronic Kidney Disease, Blood Pressure, Angiotensin-converting Enzyme Inhibitor Trial in San Francisco (Continuation of ACEi

      Active, not recruiting
      • Chronic Kidney Disease
      • +3 more
      • Continuation of ACEi and/or ARBs
      • San Francisco, California
        University of California, San Francisco
      Oct 4, 2021

      Mitral Valve Insufficiency, Left Ventricular Systolic Dysfunction Trial in Seoul (Ertugliflozin, Placebo)

      Recruiting
      • Mitral Valve Insufficiency
      • Left Ventricular Systolic Dysfunction
      • Seoul, Korea, Republic of
      • +2 more
      Jun 19, 2022